Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uveitis | 15 | 2025 | 34 | 8.370 |
Why?
|
| Autoimmune Diseases | 14 | 2025 | 233 | 7.290 |
Why?
|
| T-Lymphocytes, Regulatory | 10 | 2025 | 219 | 5.060 |
Why?
|
| Receptors, Melanocortin | 8 | 2021 | 8 | 3.880 |
Why?
|
| Receptor, Adenosine A2A | 4 | 2023 | 17 | 1.940 |
Why?
|
| Receptors, Immunologic | 3 | 2023 | 179 | 1.390 |
Why?
|
| Spleen | 6 | 2020 | 482 | 1.380 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2019 | 62 | 1.040 |
Why?
|
| Retinitis | 2 | 2020 | 6 | 1.000 |
Why?
|
| Mice, Inbred C57BL | 11 | 2025 | 3450 | 0.980 |
Why?
|
| Chemokine CCL20 | 1 | 2025 | 3 | 0.920 |
Why?
|
| CTLA-4 Antigen | 1 | 2025 | 73 | 0.910 |
Why?
|
| Eye | 2 | 2023 | 54 | 0.880 |
Why?
|
| Autoimmunity | 3 | 2021 | 240 | 0.850 |
Why?
|
| Retina | 2 | 2021 | 126 | 0.730 |
Why?
|
| Mice | 12 | 2025 | 11003 | 0.690 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 2238 | 0.670 |
Why?
|
| Uvea | 1 | 2020 | 1 | 0.650 |
Why?
|
| Serpins | 1 | 2020 | 19 | 0.640 |
Why?
|
| Animals | 15 | 2025 | 20962 | 0.640 |
Why?
|
| Mice, Knockout | 6 | 2025 | 2140 | 0.620 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2019 | 35 | 0.590 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 247 | 0.570 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 761 | 0.530 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 679 | 0.510 |
Why?
|
| Receptors, Adenosine A2 | 1 | 2016 | 4 | 0.510 |
Why?
|
| Cell Polarity | 1 | 2016 | 109 | 0.490 |
Why?
|
| Antigen-Presenting Cells | 2 | 2019 | 178 | 0.490 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1019 | 0.460 |
Why?
|
| Forkhead Transcription Factors | 4 | 2020 | 131 | 0.440 |
Why?
|
| Disease Progression | 1 | 2019 | 1176 | 0.440 |
Why?
|
| B7-H1 Antigen | 1 | 2015 | 59 | 0.440 |
Why?
|
| alpha-MSH | 2 | 2015 | 3 | 0.420 |
Why?
|
| Self Tolerance | 1 | 2013 | 20 | 0.410 |
Why?
|
| Macrophages | 1 | 2019 | 1053 | 0.400 |
Why?
|
| MicroRNAs | 1 | 2019 | 697 | 0.380 |
Why?
|
| Dendritic Cells | 1 | 2015 | 528 | 0.360 |
Why?
|
| Obesity | 1 | 2019 | 1247 | 0.340 |
Why?
|
| Retinol-Binding Proteins | 3 | 2013 | 4 | 0.270 |
Why?
|
| Eye Proteins | 3 | 2013 | 74 | 0.260 |
Why?
|
| Autoantigens | 2 | 2019 | 137 | 0.240 |
Why?
|
| Humans | 10 | 2025 | 64244 | 0.230 |
Why?
|
| Receptors, CCR6 | 1 | 2025 | 9 | 0.230 |
Why?
|
| Freund's Adjuvant | 2 | 2019 | 14 | 0.230 |
Why?
|
| Cytokines | 2 | 2019 | 944 | 0.210 |
Why?
|
| Receptors, CCR7 | 1 | 2023 | 9 | 0.200 |
Why?
|
| Antigens, CD | 2 | 2015 | 348 | 0.190 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2013 | 25 | 0.190 |
Why?
|
| Antigens | 1 | 2023 | 149 | 0.190 |
Why?
|
| Inflammation | 2 | 2023 | 1162 | 0.190 |
Why?
|
| Genetic Therapy | 1 | 2009 | 802 | 0.180 |
Why?
|
| Cells, Cultured | 2 | 2020 | 2176 | 0.180 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1621 | 0.160 |
Why?
|
| Immunomodulation | 1 | 2019 | 32 | 0.150 |
Why?
|
| CD11 Antigens | 1 | 2019 | 16 | 0.150 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 165 | 0.150 |
Why?
|
| Organ Specificity | 1 | 2019 | 196 | 0.140 |
Why?
|
| Interleukin-17 | 1 | 2019 | 101 | 0.140 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 178 | 0.140 |
Why?
|
| Th1 Cells | 1 | 2019 | 173 | 0.140 |
Why?
|
| Immunity | 1 | 2019 | 107 | 0.140 |
Why?
|
| Microglia | 1 | 2021 | 250 | 0.140 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 176 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 645 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2019 | 3070 | 0.130 |
Why?
|
| Interferon-gamma | 1 | 2019 | 576 | 0.130 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 1297 | 0.120 |
Why?
|
| Melanocortins | 1 | 2015 | 1 | 0.120 |
Why?
|
| Convalescence | 1 | 2015 | 18 | 0.110 |
Why?
|
| Neuropilin-1 | 1 | 2015 | 12 | 0.110 |
Why?
|
| Adenosine | 1 | 2015 | 78 | 0.110 |
Why?
|
| Biomarkers | 1 | 2019 | 1431 | 0.100 |
Why?
|
| Apyrase | 1 | 2013 | 4 | 0.100 |
Why?
|
| 5'-Nucleotidase | 1 | 2013 | 2 | 0.100 |
Why?
|
| CD11b Antigen | 1 | 2013 | 19 | 0.100 |
Why?
|
| Antigens, Ly | 1 | 2013 | 44 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1130 | 0.100 |
Why?
|
| CD4 Antigens | 1 | 2013 | 151 | 0.100 |
Why?
|
| Adoptive Transfer | 1 | 2011 | 149 | 0.090 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 302 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 174 | 0.080 |
Why?
|
| Aqueous Humor | 1 | 2009 | 4 | 0.080 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2009 | 24 | 0.080 |
Why?
|
| Injections | 1 | 2009 | 82 | 0.070 |
Why?
|
| Protein Engineering | 1 | 2009 | 85 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 1196 | 0.070 |
Why?
|
| Vaccines, DNA | 1 | 2009 | 98 | 0.070 |
Why?
|
| Plasmids | 1 | 2009 | 293 | 0.070 |
Why?
|
| Models, Animal | 1 | 2009 | 240 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 172 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 891 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2009 | 417 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2015 | 1540 | 0.060 |
Why?
|
| Adult | 1 | 2019 | 17117 | 0.050 |
Why?
|
| Middle Aged | 1 | 2019 | 17899 | 0.050 |
Why?
|
| Male | 1 | 2019 | 30295 | 0.040 |
Why?
|
| Female | 1 | 2019 | 33351 | 0.030 |
Why?
|